ARCT R&D Expenses
Arcturus Therapeutics Holdings Inc · R&D Expenses
ARCT R&D Expenses
Latest reported$17.52Mperiod ending
ARCT Quarterly R&D Expenses ($231.00K → $17.52M)
Quarterly R&D Expenses
High-resolution chart · PNG
ARCT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 17,515,000 | |
| 20,925,000 | |
| 24,476,000 | |
| 23,265,000 | |
| 29,579,000 | |
| 34,893,000 | |
| 43,780,000 | |
| 39,134,000 | |
| 58,669,000 | |
| 53,573,000 | |
| 36,620,000 | |
| 51,077,000 | |
| 52,668,000 | |
| 51,768,000 | |
| 26,981,000 | |
| 37,688,000 | |
| 38,189,000 | |
| 44,893,000 | |
| 32,633,000 | |
| 45,398,000 | |
| 45,679,000 | |
| 50,050,000 | |
| 24,286,000 | |
| 17,699,000 | |
| 7,944,000 | |
| 7,917,000 | |
| 11,994,000 | |
| 7,053,000 | |
| 7,269,000 | |
| 7,324,000 | |
| 4,847,000 | |
| 3,969,000 | |
| 4,225,000 | |
| 3,941,000 | |
| 11,356,000 | |
| 1,059,000 | |
| 1,443,000 | |
| 2,060,000 | |
| 4,447,000 | |
| 6,400,000 | |
| 4,182,000 | |
| 3,362,000 | |
| 3,335,000 | |
| 2,853,000 | |
| 3,683,000 | |
| 3,590,000 | |
| 4,908,000 | |
| 8,757,000 | |
| 5,918,000 | |
| 5,522,000 | |
| 4,603,000 | |
| 2,067,000 | |
| 321,000 | |
| 75,000 | |
| 67,000 | |
| 119,000 | |
| 231,000 |